AMRX insider trading — Amneal Pharmaceuticals, Inc.
Over the last 90 days, insiders at Amneal Pharmaceuticals, Inc. (AMRX) made 0 open-market purchases worth $0 and 4 open-market sales worth $7.22M, making them net sellers by $7.22M. The largest sale was by Daly Jason B. (EVP, Chief Legal Officer), who sold 210,000 shares for $3.65M on Aug 12, 2026.
Updated Oct 16, 2026.
Recent AMRX insider transactions
Every Form 4 filed by Amneal Pharmaceuticals, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Buchi J Kevin | Director | G · Gift | Direct | 20,445 | — | — | Form 4 |
| Sep 11, 2026 | Buchi J Kevin | Director | M · Option exercise | Direct | 20,445 | $14.45 | $295K | Form 4 |
| Sep 1, 2026 | Boyer Andrew S | Executive Vice President | G · Gift | Direct | 80,000 | — | — | Form 4 |
| Aug 21, 2026 | Boyer Andrew S | Executive Vice President | G · Gift | Direct | 152,426 | — | — | Form 4 |
| Aug 13, 2026 | Kiely John | Director | S · Sale | Direct | 50,000 | $17.64 | $882K | Form 4 |
| Aug 13, 2026 | Kiely John | Director | G · Gift | Direct | 10,000 | — | — | Form 4 |
| Aug 12, 2026 | Shah Nikita | Executive Vice President | S · Sale | Direct | 146,403 | $17.51 | $2.56M | Form 4 |
| Aug 12, 2026 | Daly Jason B. | EVP, Chief Legal Officer | S · Sale | Direct | 210,000 | $17.40 | $3.65M | Form 4 |
| Aug 11, 2026 | Buchi J Kevin | Director | M · Option exercise | Indirect | 168,573 | $17.18 | $2.90M | Form 4 |
| Aug 11, 2026 | Daly Jason B. | EVP, Chief Legal Officer | S · Sale | Direct | 6,613 | $17.70 | $117K | Form 4 |
| Aug 10, 2026 | Patel Tushar Bhikhubhai | 10% Owner | A · Grant/award | Indirect | 12,763,469 | — | — | Form 4 |
| Aug 10, 2026 | Patel Chintu | Co-CEO | A · Grant/award | Indirect | 6,381,734 | — | — | Form 4 |
| Aug 10, 2026 | Patel Gautam | Director | A · Grant/award | Indirect | 283,632 | — | — | Form 4 |
| Aug 10, 2026 | Patel Chirag K. | President & Co-CEO | A · Grant/award | Indirect | 6,381,734 | — | — | Form 4 |
AMRX insider trading FAQ
Are insiders buying AMRX stock?
Not on the open market. In the last 90 days, Amneal Pharmaceuticals, Inc. insiders made no open-market purchases, and 4 open-market sales totaling $7.22M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading AMRX?
Recent sellers: Daly Jason B., Kiely John, Shah Nikita.
Where does AMRX insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.